Wordt geladen...
Increased uptake of [(123)I]-meta-iodobenzylguanidine and [(18)F]-dopamine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors romidepsin and trichostatin A
PURPOSE: [(131)I]-meta-iodobenzylguanidine ([(131)I]-MIBG) is the most commonly employed treatment for metastatic pheochromocytoma and paraganglioma; however, its success is limited. Its efficacy depends on the [(131)I]-MIBG concentration reached within the tumor through its uptake via the norepinep...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2011
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110720/ https://ncbi.nlm.nih.gov/pubmed/21098082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1677/ERC-10-0090 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|